Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
O-I Glass | OI | Dec 24, 2024 | 10.20 | +0.59 |
Oak Valley Bancorp | OVLY | Dec 24, 2024 | 28.55 | +0.99 |
Oak Woods Acquisition | OAKU | Dec 24, 2024 | 11.35 | 0.00 |
Oaktree Acquisition III Life Sciences Unit | OACCU | Dec 24, 2024 | 10.09 | 0.00 |
Oaktree Capital A Pref | OAK-A | Dec 24, 2024 | 21.99 | -0.72 |
Oaktree Capital Group B Pref | OAK-B | Dec 24, 2024 | 21.31 | -0.61 |
Oaktree Specialty | OCSL | Dec 24, 2024 | 15.24 | +1.67 |
Oatly ADR | OTLY | Dec 24, 2024 | 0.61 | -0.60 |
Oblong | OBLG | Dec 24, 2024 | 3.60 | +1.98 |
Occidental Petroleum | OXY | Dec 24, 2024 | 48.12 | +0.59 |
Ocean Biomedical | OCEA | Dec 24, 2024 | 0.59 | -7.83 |
Ocean Power Technologies | OPTT | Dec 24, 2024 | 0.33 | -1.59 |
Oceaneering International | OII | Dec 24, 2024 | 25.04 | +1.01 |
OceanFirst Financial | OCFC | Dec 24, 2024 | 17.98 | +0.73 |
OceanFirst Pref | OCFCP | Dec 24, 2024 | 25.21 | 0.00 |
OceanPal | OP | Dec 24, 2024 | 1.07 | -1.83 |
Ocugen | OCGN | Dec 24, 2024 | 0.72 | -2.96 |
Ocular Therapeutix | OCUL | Dec 24, 2024 | 8.33 | -2.69 |
Oculis | OCS | Dec 24, 2024 | 16.99 | +0.98 |
Oddity Tech | ODD | Dec 24, 2024 | 44.67 | +0.20 |
Odyssey Marine Exploration | OMEX | Dec 24, 2024 | 0.40 | +16.16 |
Offerpad Solutions A | OPAD | Dec 24, 2024 | 3.40 | -0.58 |
Office Properties | OPI | Dec 24, 2024 | 1.01 | +2.68 |
OFG Bancorp | OFG | Dec 24, 2024 | 43.27 | +1.67 |
OFS Capital | OFS | Dec 24, 2024 | 8.04 | +1.01 |
OFS Credit | OCCI | Dec 24, 2024 | 7.13 | +0.21 |
OFS Credit C Pref | OCCIO | Dec 24, 2024 | 24.55 | 0.00 |
OFS Credit Company Pref F | OCCIM | Dec 24, 2024 | 24.80 | 0.00 |
OFS Credit E Pref | OCCIN | Dec 24, 2024 | 23.64 | -0.15 |
OGE Energy | OGE | Dec 24, 2024 | 41.50 | +0.53 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.